Sugi Predict

Sugi Predict / Compounds / SCHEMBL461571

SCHEMBL461571

SCHEMBL461571

NC(=O)CCC(NCc1ccccc1)C(=O)O

nearest known ligand 0.54

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
▸ KMT2A Q03164 1/20 0.54
▸ MMP2 P08253 4/20 0.52
▸ MMP9 P14780 4/20 0.52
▸ ALDH1A1 P00352 1/20 0.50
▸ RAB9A P51151 1/20 0.50
▸ NAALAD2 Q9Y3Q0 1/20 0.47
▸ MEP1B Q16820 2/20 0.46
▸ FOLH1 Q04609 1/20 0.46
▸ TLR2 O60603 1/20 0.45
▸ GGT1 P19440 3/20 0.45
▸ CA2 P00918 2/20 0.45
▸ CA1 P00915 1/20 0.45
▸ MMP8 P22894 1/20 0.44
▸ MMP12 P39900 1/20 0.44
▸ MMP14 P50281 1/20 0.44
▸ PRMT1 Q99873 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL461572 1.00 KMT2A (0.54) KMT2AMMP2MMP9ALDH1A1RAB9A
SCHEMBL27520105 0.89 TLR2 (0.46) KMT2AMMP2MMP9ALDH1A1RAB9A
SCHEMBL14394199 0.88 KMT2A (0.45) KMT2AMMP2MMP9ALDH1A1RAB9A
SCHEMBL2251543 0.87 FFAR1 (0.46) KMT2AMMP2MMP9
SCHEMBL1818651 0.87 NAALAD2 (0.60) MMP9NAALAD2MEP1BFOLH1MMP8
SCHEMBL3387298 0.87 NAALAD2 (0.60) MMP9NAALAD2MEP1BFOLH1MMP8
SCHEMBL869873 0.87 NAALAD2 (0.60) MMP9NAALAD2MEP1BFOLH1MMP8
SCHEMBL2250167 0.86 L3MBTL1 (0.51) KMT2AMMP2MMP9ALDH1A1CA2
SCHEMBL2252839 0.86 FOLH1 (0.49) KMT2AMMP2MMP9FOLH1CA2
SCHEMBL2247510 0.86 FOLH1 (0.49) KMT2AMMP2MMP9ALDH1A1FOLH1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 31 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-113914124-A Modified nano-cellulose and application thereof in preparation of base paper 华邦特西诺采新材料股份有限公司 2022-01-11 — — CN claimed
EP-2089417-A2 METHODS, COMPOUNDS, COMPOSITIONS AND VEHICLES FOR DELIVERING 3-AMINO-1-PROPANESULFONIC ACID BELLUS Health (International) Limited (CH) 2009-08-19 — — EP claimed
WO-2009019534-A2 METHODS, COMPOUNDS, COMPOSITIONS AND VEHICLES FOR DELIVERING 3-AMINO-1-PROPANESULFONIC ACID BELLUS HEALTH (INTERNATIONAL) LIMITED (US) 2009-02-12 — — WO claimed
EP-0552417-B1 Cyclic peptides and use thereof TAKEDA CHEMICAL INDUSTRIES LTD (JP) 1999-07-07 — — EP claimed
EP-0528312-B1 Cyclic peptides and use thereof TAKEDA CHEMICAL INDUSTRIES LTD (JP) 1997-07-16 — — EP claimed
CN-116333294-B Catalyst for preparing block polyether and preparation method of block polyether 辽宁奥克药业股份有限公司 2023-12-29 — — CN disclosed
CN-116333294-A Catalyst for preparing block polyether and preparation method of block polyether 辽宁奥克药业股份有限公司 2023-06-27 — — CN disclosed
CN-113914124-A Modified nano-cellulose and application thereof in preparation of base paper 华邦特西诺采新材料股份有限公司 2022-01-11 — — CN disclosed
CN-113914124-A Modified nano-cellulose and application thereof in preparation of base paper 华邦特西诺采新材料股份有限公司 2022-01-11 — — CN disclosed
CN-109369445-B Radioactive glutamine derivatives for diagnosis and treatment and process for preparing the same 首都医科大学 2021-10-15 — — CN disclosed
CN-109369445-A Radioactivity Glutamine Derivatives and preparation method thereof for diagnosing and treating 首都医科大学 2019-02-22 — — CN disclosed
CN-106946748-B Deliver method, compound, composition and the carrier of 3-APS BHI有限合资公司 2019-02-05 — — CN disclosed
US-20070093501-A1 Urea derivative, process for producing the same, and use TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2007-04-26 — — US disclosed
EP-1695961-A1 UREA DERIVATIVE, PROCESS FOR PRODUCING THE SAME, AND USE Takeda Pharmaceutical Company Limited (JP) 2006-08-30 — — EP disclosed
US-20020058622-A1 Sustained-release preparation IGARI YASUTAKA (JP) 2002-05-16 — — US disclosed
US-6376461-B1 WATER INSOLUBLE OR SLIGHTLY WATER SOLUBLE POLYVALENT METAL SALT OF A GROWTH HORMONE, AND A BIODEGRADABLE POLYMER; ENDOTHELIN ANTAGONIST TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) 2002-04-23 — — US disclosed
US-6251861-B1 CYCLO(D-ASP-ASP(R1)-ASP-D-THG(2)-LEU-TRP) DISODIUM SALT, WHERE ASP(R1) IS AN ASPARTIC ACID BETA-4-PHENYLPIPERAZINE AMIDE RESIDUE AND THG(2) IS 2-(2-THIENYL)GLYCINE; ANTI-ENDOTHELIN ACTIVITY TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) 2001-06-26 — — US disclosed
EP-0552417-B1 Cyclic peptides and use thereof TAKEDA CHEMICAL INDUSTRIES LTD (JP) 1999-07-07 — — EP disclosed
EP-0815870-A2 Composition for prohylaxis or treatment of cerebral infarction Takeda Chemical Industries, Ltd. (JP) 1998-01-07 — — EP disclosed
EP-0528312-B1 Cyclic peptides and use thereof TAKEDA CHEMICAL INDUSTRIES LTD (JP) 1997-07-16 — — EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020058622-A1 Sustained-release preparation EDNRA, EDNRB, ORAI1 KMT2A 2035/4885MMP2 401/4885MMP9 561/4885
US-20070093501-A1 Urea derivative, process for producing the same, and use F2, URB2, F12 KMT2A 2013/4885MMP2 2879/4885MMP9 3573/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.